Metabolism of antiepileptic drugs:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
New York
Raven Pr.
1984
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XVI, 245 S. |
| ISBN: | 0881670006 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV000173426 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 870612s1984 |||| 00||| eng d | ||
| 020 | |a 0881670006 |9 0-88167-000-6 | ||
| 035 | |a (OCoLC)10457072 | ||
| 035 | |a (DE-599)BVBBV000173426 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-188 | ||
| 050 | 0 | |a RM322 | |
| 082 | 0 | |a 615/.784 |2 19 | |
| 245 | 1 | 0 | |a Metabolism of antiepileptic drugs |c ed.: René H. Levy ... |
| 264 | 1 | |a New York |b Raven Pr. |c 1984 | |
| 300 | |a XVI, 245 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 4 | |a Anticonvulsivants - Effets physiologiques | |
| 650 | 4 | |a Anticonvulsivants - Métabolisme | |
| 650 | 4 | |a Interactions médicamenteuses | |
| 650 | 4 | |a Pharmacocinétique | |
| 650 | 4 | |a Anticonvulsants |x Metabolism | |
| 650 | 4 | |a Anticonvulsants |x Physiological effect | |
| 650 | 4 | |a Anticonvulsants |x metabolism |v Congresses | |
| 650 | 4 | |a Drug interactions | |
| 650 | 4 | |a Pharmacokinetics | |
| 650 | 0 | 7 | |a Pharmakokinetik |0 (DE-588)4115557-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Antiepileptikum |0 (DE-588)4142656-3 |2 gnd |9 rswk-swf |
| 651 | 7 | |a Phoenix, Ariz. |0 (DE-588)4119970-4 |2 gnd |9 rswk-swf | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Antiepileptikum |0 (DE-588)4142656-3 |D s |
| 689 | 0 | 1 | |a Pharmakokinetik |0 (DE-588)4115557-9 |D s |
| 689 | 0 | 2 | |a Phoenix, Ariz. |0 (DE-588)4119970-4 |D g |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Levy, René H. |e Sonstige |4 oth | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000099168&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-000099168 | ||
Datensatz im Suchindex
| _version_ | 1804114633160654848 |
|---|---|
| adam_text | METABOLISM OF ANTIEPILEPTIC DRUGS EDITORS RENE H. LEVY, PH.D.
DEPARTMENTS OF PHARMACEUTICS AND NEUROLOGICAL SURGERY UNIVERSITY OF
WASHINGTON SEATTLE, WASHINGTON WILLIAM H. PITLICK, PH.D. NATIONAL
INSTITUTE OF NEUROLOGICAL AND COMMUNICATIVE DISORDERS AND STROKE
NATIONAL INSTITUTES OF HEALTH BETHESDA, MARYLAND MICHAEL EICHELBAUM,
M.D. DEPARTMENT OF MEDICINE UNIVERSITY OF BONN BONN, FEDERAL REPUBLIC OF
GERMANY JAAP MEIJER INSTITUUT VOOR EPILEPSIEBESTRIJDING HEEMSTEDE, THE
NETHERLANDS UNIVC-ISIRATS- BIBLIO THEK RAVEN PRESS NEW YORK CONTENTS
ADVANCES IN METHODOLOGY 1 USE OF STABLE ISOTOPES IN THE STUDY OF DRUG
METABOLISM AND DISPOSITION IN EPILEPSY*PRINCIPLES T.A. BAILLIE 9 USE OF
STABLE ISOTOPES IN STUDYING PHARMACOKINETICS AND INTERACTIONS OF
ANTIEPILEPTIC DRUGS H. I KUPFERBERG CARBAMAZEPINE 19 KINETICS AND
METABOLISM OF CARBAMAZEPINE-10,11-EPOXIDE IN MAN L. BERTILSSON AND T.
TOMSON 27 IN VIVO AND IN VITRO BIOTRANSFORMATIO N OF CARBAMAZEPINE IN
MAN AND RAT M. EICHELBAUM, C. JENSEN, W. VON SASSEN, L. BERTILSSON, AND
T. TOMSON 35 CARBAMAZEPINE SUSPENSION FOR ACUTE TREATMENT OF TRIGEMINAL
NEURALGIA: CLINICAL EFFECTS IN RELATION TO PLASMA CONCENTRATION D.
SCHMIDT, C. CORNAGGIA, AND A. FABIAN 45 INTERACTION BETWEEN VALPROIC
ACID AND CARBAMAZEPINE IN EPILEPTIC PATIENTS R.H. LEVY, PL. MORSELLI, G.
BIANCHETTI, M. GUYOT, A. BRACHET-LIERMAIN, AND P. LOISEAU 53 MECHANISMS
OF INTERACTION BETWEEN SODIUM VALPROATE AND CARBAMAZEPINE IN THE RHESUS
MONKEY AND IN THE ISOLATED PERFUSED RAT LIVER T.A. MOR ELAND, S.-L.
CHANG, AND R.H. LEVY 61 SERUM CONCENTRATION PROFILE STUDIES OF TABLETS
AND SUPPOSITORIES OF VALPROATE AND CARBAMAZEPINE IN HEALTHY SUBJECTS AND
PATIENTS WITH EPILEPSY S. I. JOHANNESSEN, O. HENRIKSEN, A. W.
MUNTHE-KAAS, AND B. SALVESEN VU VIII CONTENTS VALPROIC ACID 73
RESPONSIBILITY OF THE METABOLITE PATTERN FOR POTENTIAL SIDE-EFFECTS IN
THE RAT BEING TREATED WITH VALPROIC ACID, 2-PROPYLPENTEN-2-OIC ACID, AND
2-PROPYLPENTEN-4-OIC ACID H. SCHDFER AND R. LIIHRS 85 DISPOSITION,
EMBRYOTOXICITY, AND TERATOGENICITY OF VALPROIC ACID IN THE MOUSE AS
RELATED TO MAN H. NAU, H.-J. MERKER, K. BRENDEL, CH. GANSAU, I. HDUSER,
AND W. WITTFOHT 97 ASPECTS OF THE DOSE-DEPENDENT METABOLISM OF VALPROIC
ACID G.R. GRANNEMAN, T.B. MARRIOTT, S.I. WANG, L.T. SENNELLO, N. S.
HAGEN, AND R. C. SONDERS 105 VARIABLE FREE AND TOTAL VALPROIC ACID
CONCENTRATIONS IN SOLE AND MULTI-DRUG THERAPY J.A. CRAMER, R.H. MATTSON,
D.M. BENNETT, AND C.T. SWICK 115 SODIUM VALPROATE PLASMA LEVELS (TOTAL
LEVEL AND FREE FRACTION LEVEL) IN EPILEPTIC PATIENTS: INFLUENCE OF DOSE,
AGE, AND ASSOCIATED THERAPY E. MESDJIAN, C. DRAVET, AND J. ROGER 129
BLOOD-BRAIN BARRIER PERMEABILITY TO ANTICONVULSANT DRUGS E. M. CORNFORD
143 PHARMACOKINETIC EVALUATION OF NOVEL SUSTAINED RELEASED DOSAGE FORM
OF VALPROIC ACID AND INTRAVENOUS PREPARATION OF VALPROMIDE IN DOGS M.
BIALER, M. FRIEDMAN, A. RUBINSTEIN, AND J. DUBROVSKY 153 VALPROATE
NONREVERSIBILITY: DOSING PROCEDURES CRITICAL? J. S. LOCKARD, R. H. LEVY,
W. C. CONGDON, L. L. DUCHARME, AND PH. RHODES 169 EFFECT OF VALPROIC
ACID ON AMINO ACID AND ORGANIC ACID METABOLISM /. MATSUMOTO, T. KUHARA,
T. SHINKA, Y. INOUE, AND M. MATSUMOTO 177 FOLIC ACID METABOLISM: EFFECT
OF CARBAMAZEPINE AND VALPROATE P. WINKEL, M. DAM, L. GRAM, J. HENDEL,
AND I. J0RGENSEN NEW ANTIEPILEPTIC DRUGS 183 METABOLIC STUDIES OF
PROGABIDE (SL 76.002) IN THE RAT B. FERRANDES, A. DURAND, J.
FRAISSE-ANDRE, AND PL. MORSELLI 191 PHARMACOKINETIC PROFILE OF PROGABIDE
IN FIVE ANIMAL SPECIES AND MAN P. L. MORSELLI, J. T. BURKE, B.
FERRANDES, P. PADOVANI, G. BIANCHETTI, R. GOMENI, J. P. THENOT, AND J.
P. THIERCELIN CONTENTS IX 199 PHARMACOKINETIC PROPERTIES AND METABOLIC
PROFILE OF STIRIPENTOL IN PRIMATES H.-S. LIN, R.H. LEVY, H. BLEHAUT, AND
J. TOR 209 PHARMACOKINETICS OF CI-912 IN EPILEPTIC PATIENTS A.J.
WILENSKY, P.N. FRIEL, L.M. OJEMANN, M.J. ALMES, R.H. LEVY, AND R.A.
BUCHANAN 217 EFFECT OF CARBAMAZEPINE ON THE MICHAELIS-MENTEN PARAMETERS
OF PHENYTOIN /. E. LEPPIK, S. M. PEPIN, J. JACOBI, AND K. W. MILLER 223
PLASMA CLEARANCE OF NOR-METHSUXIMIDE IN A UREMIC PATIENT H. KUTT, C. E.
PIPPENGER, D. C. DE VIVO, AND P. PHILLIPS 227 USE OF PHARMACOKINETICS IN
CLINICAL TRIALS OF ANTIEPILEPTIC DRUGS W.H. PITLICK 235 CONTRIBUTION OF
SIMULATION IN THE STUDY OF THE TIME-DEPENDENCE AND CLINICAL RESPONSE OF
CLOBAZAM H. BUN, A. ILIADIS, R. BRUNO, J. P. CANO, C. DRAVET, AND J.
ROGER 241 SUBJECT INDEX
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV000173426 |
| callnumber-first | R - Medicine |
| callnumber-label | RM322 |
| callnumber-raw | RM322 |
| callnumber-search | RM322 |
| callnumber-sort | RM 3322 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| ctrlnum | (OCoLC)10457072 (DE-599)BVBBV000173426 |
| dewey-full | 615/.784 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.784 |
| dewey-search | 615/.784 |
| dewey-sort | 3615 3784 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01850nam a2200493 c 4500</leader><controlfield tag="001">BV000173426</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">870612s1984 |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0881670006</subfield><subfield code="9">0-88167-000-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)10457072</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV000173426</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM322</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.784</subfield><subfield code="2">19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Metabolism of antiepileptic drugs</subfield><subfield code="c">ed.: René H. Levy ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Raven Pr.</subfield><subfield code="c">1984</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVI, 245 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anticonvulsivants - Effets physiologiques</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anticonvulsivants - Métabolisme</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Interactions médicamenteuses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacocinétique</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anticonvulsants</subfield><subfield code="x">Metabolism</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anticonvulsants</subfield><subfield code="x">Physiological effect</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anticonvulsants</subfield><subfield code="x">metabolism</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug interactions</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacokinetics</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakokinetik</subfield><subfield code="0">(DE-588)4115557-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Antiepileptikum</subfield><subfield code="0">(DE-588)4142656-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Phoenix, Ariz.</subfield><subfield code="0">(DE-588)4119970-4</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Antiepileptikum</subfield><subfield code="0">(DE-588)4142656-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakokinetik</subfield><subfield code="0">(DE-588)4115557-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Phoenix, Ariz.</subfield><subfield code="0">(DE-588)4119970-4</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Levy, René H.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000099168&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000099168</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| geographic | Phoenix, Ariz. (DE-588)4119970-4 gnd |
| geographic_facet | Phoenix, Ariz. |
| id | DE-604.BV000173426 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T15:09:49Z |
| institution | BVB |
| isbn | 0881670006 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000099168 |
| oclc_num | 10457072 |
| open_access_boolean | |
| owner | DE-12 DE-188 |
| owner_facet | DE-12 DE-188 |
| physical | XVI, 245 S. |
| publishDate | 1984 |
| publishDateSearch | 1984 |
| publishDateSort | 1984 |
| publisher | Raven Pr. |
| record_format | marc |
| spelling | Metabolism of antiepileptic drugs ed.: René H. Levy ... New York Raven Pr. 1984 XVI, 245 S. txt rdacontent n rdamedia nc rdacarrier Anticonvulsivants - Effets physiologiques Anticonvulsivants - Métabolisme Interactions médicamenteuses Pharmacocinétique Anticonvulsants Metabolism Anticonvulsants Physiological effect Anticonvulsants metabolism Congresses Drug interactions Pharmacokinetics Pharmakokinetik (DE-588)4115557-9 gnd rswk-swf Antiepileptikum (DE-588)4142656-3 gnd rswk-swf Phoenix, Ariz. (DE-588)4119970-4 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Antiepileptikum (DE-588)4142656-3 s Pharmakokinetik (DE-588)4115557-9 s Phoenix, Ariz. (DE-588)4119970-4 g DE-604 Levy, René H. Sonstige oth GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000099168&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Metabolism of antiepileptic drugs Anticonvulsivants - Effets physiologiques Anticonvulsivants - Métabolisme Interactions médicamenteuses Pharmacocinétique Anticonvulsants Metabolism Anticonvulsants Physiological effect Anticonvulsants metabolism Congresses Drug interactions Pharmacokinetics Pharmakokinetik (DE-588)4115557-9 gnd Antiepileptikum (DE-588)4142656-3 gnd |
| subject_GND | (DE-588)4115557-9 (DE-588)4142656-3 (DE-588)4119970-4 (DE-588)1071861417 |
| title | Metabolism of antiepileptic drugs |
| title_auth | Metabolism of antiepileptic drugs |
| title_exact_search | Metabolism of antiepileptic drugs |
| title_full | Metabolism of antiepileptic drugs ed.: René H. Levy ... |
| title_fullStr | Metabolism of antiepileptic drugs ed.: René H. Levy ... |
| title_full_unstemmed | Metabolism of antiepileptic drugs ed.: René H. Levy ... |
| title_short | Metabolism of antiepileptic drugs |
| title_sort | metabolism of antiepileptic drugs |
| topic | Anticonvulsivants - Effets physiologiques Anticonvulsivants - Métabolisme Interactions médicamenteuses Pharmacocinétique Anticonvulsants Metabolism Anticonvulsants Physiological effect Anticonvulsants metabolism Congresses Drug interactions Pharmacokinetics Pharmakokinetik (DE-588)4115557-9 gnd Antiepileptikum (DE-588)4142656-3 gnd |
| topic_facet | Anticonvulsivants - Effets physiologiques Anticonvulsivants - Métabolisme Interactions médicamenteuses Pharmacocinétique Anticonvulsants Metabolism Anticonvulsants Physiological effect Anticonvulsants metabolism Congresses Drug interactions Pharmacokinetics Pharmakokinetik Antiepileptikum Phoenix, Ariz. Konferenzschrift |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000099168&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT levyreneh metabolismofantiepilepticdrugs |